NCT07736352
Exploration of Appropriate BIS Range and Propofol Effect-site Concentration During Total Intravenous Anesthesia With Concomitant Adjuvants.
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Recruitment opened Show 4 more changesShow less
- Eligibility criteria expanded, about 14 words
- Study sites: 0 to 1
- Start date changed from estimate of Aug 1, 2026 to Jul 30, 2026
- Secondary endpoints: details revised at 4 of 6 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
BIS value
Timeframe: From the start of the intra-operative stepwise reduction phase until the first occurrence of IFT positivity or any predefined clinical sign of inadequate anesthesia, assessed up to 30 minutes.
Propofol Effect-Site Concentration
Timeframe: From the start of the intra-operative stepwise reduction phase until the first occurrence of IFT positivity or any predefined clinical sign of inadequate anesthesia, assessed up to 30 minutes.
Secondary (6)
Modified Brice Questionnaire
Time from Discontinuation of Anesthetics to Laryngeal Mask Airway Removal
Time to Modified Aldrete Score of 10 in the Post Anesthesia Care Unit
Adverse Events During Emergence from Anesthesia
Postoperative Pain Intensity Measured by Numeric Rating Scale
Show 1 moreShow less
Analgesic Consumption
Arms and interventions
Propofol + RemifentanilSham comparator
Propofol + Remifentanil + MidazolamExperimental
Propofol + Remifentanil + DexmedetomidineExperimental
Propofol + Remifentanil + EsketamineExperimental
Drugs: Propofol + Remifentanil +Midazolam, Propofol + Remifentanil + Dexmedetomidine, Propofol + Remifentanil + Esketamine, Propofol + Remifentanil
Sites
1 site in 1 country
- China-Japan Friendship HospitalBeijing, China